New stem cell technology gives high-risk leukemia patients second chance at life
Positive results from a recent clinical trial show that a Canadian-made stem cell innovation could reduce risks and improve outcomes of cord blood stem cell transplantation for patients with leukemia and lymphoma. OTTAWA, November 5, […]